Altogether, the combined data approved the potential of VA + BTZ synthesized NPs in surpassing the interaction between TGF-β1 and NF-κB signaling pathways and further attenuating hepatic fibrosis in a CCL4-induced mouse model of hepatic fibrosis. The gene discussed is CCL4; the disease is Hepatic fibrosis.